This study explored whether adding a drug to standard hormone treatment, given before radiotherapy begins, could improve outcomes for men at this earlier stage of the disease. Prostate cancer that hasn’t spread beyond the prostate is usually treated with a combination of hormone therapy and radiotherapy. The drug in this trial works by cutting off the supply of male hormones like testosterone that fuel cancer growth, and was already shown to help men with advanced prostate cancer.
According to the Irish Cancer Society, about 4,0002 men are diagnosed with prostate cancer each year in Ireland, meaning 1 in 6 men will be diagnosed with it during their lifetime.